Header Logo

Connection

Gary Raskob to Antithrombin III

Back to Details
This is a "connection" page, showing publications Gary Raskob has written about Antithrombin III.
Gary Raskob
Connection Strength
0.020
Antithrombin III
  1. A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. Blood. 2008 Sep 15; 112(6):2242-7.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.